Edap Tms (NASDAQ:EDAP) Downgraded to “Sell” Rating by StockNews.com

StockNews.com lowered shares of Edap Tms (NASDAQ:EDAP) from a hold rating to a sell rating in a report issued on Tuesday morning.

Separately, HC Wainwright reaffirmed a “buy” rating and set a $19.00 price objective on shares of Edap Tms in a report on Thursday, August 29th.

Edap Tms Stock Up 1.7 %

EDAP opened at $2.41 on Tuesday. The company has a fifty day moving average price of $2.67 and a 200-day moving average price of $4.06. The firm has a market capitalization of $89.41 million, a P/E ratio of -3.71 and a beta of 0.38. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46. Edap Tms has a one year low of $2.27 and a one year high of $8.50.

Edap Tms (NASDAQ:EDAP) last released its quarterly earnings results on Wednesday, August 28th. The medical equipment provider reported ($0.18) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.04). The firm had revenue of $16.97 million for the quarter, compared to analysts’ expectations of $17.16 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. Equities research analysts expect that Edap Tms will post -0.6 earnings per share for the current fiscal year.

Institutional Trading of Edap Tms

A number of hedge funds have recently made changes to their positions in the stock. Orion Capital Management LLC lifted its holdings in shares of Edap Tms by 10.4% during the 3rd quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock worth $178,000 after acquiring an additional 6,600 shares during the last quarter. Parkman Healthcare Partners LLC bought a new stake in Edap Tms in the third quarter worth $395,000. BNP Paribas Financial Markets lifted its stake in Edap Tms by 23.7% in the third quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock worth $59,000 after purchasing an additional 4,400 shares during the last quarter. Redhawk Wealth Advisors Inc. bought a new stake in Edap Tms in the third quarter worth $36,000. Finally, Commonwealth Equity Services LLC lifted its stake in Edap Tms by 5.9% in the second quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock worth $388,000 after purchasing an additional 4,000 shares during the last quarter. 62.74% of the stock is owned by institutional investors.

About Edap Tms

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.